Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Significance of SARS-CoV-2 specific antibody testing during COVID-19 vaccine allocation
Akane Fujimoto, Pınar Keskinocak, İnci Yıldırım
Vaccine (2021) Vol. 39, Iss. 35, pp. 5055-5063
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Update on SARS-CoV-2 seroprevalence: regional and worldwide
Ali Rostami, Mahdi Sepidarkish, Aylar Fazlzadeh, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 12, pp. 1762-1771
Open Access | Times Cited: 70
Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review
Nuru Saadi, Y-Ling Chi, Srobana Ghosh, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 52
A structured overview of insights and opportunities for enhancing supply chain resilience
Özlem Ergün, Wallace J. Hopp, Pınar Keskinocak
IISE Transactions (2022) Vol. 55, Iss. 1, pp. 57-74
Closed Access | Times Cited: 32
COVSIM: A stochastic agent-based COVID-19 SIMulation model for North Carolina
Erik Rosenstrom, Julie S. Ivy, María E. Mayorga, et al.
Epidemics (2024) Vol. 46, pp. 100752-100752
Open Access | Times Cited: 5
Optimization modeling for pandemic vaccine supply chain management: A review and future research opportunities
S S Dey, Ali Kaan Kurbanzade, Esma S. Gel, et al.
Naval Research Logistics (NRL) (2024) Vol. 71, Iss. 7, pp. 976-1016
Open Access | Times Cited: 5
A Review of Inactivated COVID-19 Vaccine Development in China: Focusing on Safety and Efficacy in Special Populations
Lidan Hu, Jingmiao Sun, Yan Wang, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1045-1045
Open Access | Times Cited: 12
A Rapid and Sensitive Microfluidics-Based Tool for Seroprevalence Immunity Assessment of COVID-19 and Vaccination-Induced Humoral Antibody Response at the Point of Care
Kritika Srinivasan Rajsri, Michael P. McRae, Glennon W. Simmons, et al.
Biosensors (2022) Vol. 12, Iss. 8, pp. 621-621
Open Access | Times Cited: 12
The balancing role of distribution speed against varying efficacy levels of COVID-19 vaccines under variants
Daniel Kim, Pınar Keskinocak, Pelin Pekgün, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
COVID-19 vaccination challenges: A mini-review
Zeinab Mohseni Afshar, Mohammad Barary, Rezvan Hosseinzadeh, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 9
Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment
Matteo Augello, Isabell Wagenhäuser, Manuel Krone, et al.
Vaccine (2024) Vol. 42, Iss. 25, pp. 126184-126184
Closed Access | Times Cited: 1
Population differences in antibody response to SARS‐CoV‐2 infection and BNT162b2 vaccination
Guy Shapira, Ramzia Abu Hamad, Chen Weiner, et al.
The FASEB Journal (2022) Vol. 36, Iss. 4
Open Access | Times Cited: 8
Can vaccine prioritization reduce disparities in COVID-19 burden for historically marginalized populations?
Erik Rosenstrom, Jessica Mele, Julie S. Ivy, et al.
PNAS Nexus (2022) Vol. 1, Iss. 1
Open Access | Times Cited: 8
Benefits of integrated screening and vaccination for infection control
Marie Jeanne Rabil, Sait Tunç, Douglas R. Bish, et al.
PLoS ONE (2022) Vol. 17, Iss. 4, pp. e0267388-e0267388
Open Access | Times Cited: 6
Dynamic changes of SARS-CoV-2 specific IgM and IgG among population vaccinated with COVID-19 vaccine
Fengling Chen, Yi Zhong, Jiazhao Li, et al.
Epidemiology and Infection (2022) Vol. 150
Open Access | Times Cited: 5
High-Quality Masks Reduce Covid-19 Infections and Death in the US
Erik Rosenstrom, Julie S. Ivy, María E. Mayorga, et al.
2018 Winter Simulation Conference (WSC) (2021)
Closed Access | Times Cited: 6
Immunity testing against COVID-19 from blood by an IoT-enabled and AI-controlled multiplexed microfluidic platform
Nabil H. Bhuiyan, Joon S. Shim
Biosensors and Bioelectronics (2023) Vol. 244, pp. 115791-115791
Closed Access | Times Cited: 2
The Impact of Testing Capacity and Compliance With Isolation on COVID-19: A Mathematical Modeling Study
Zhuoting Yu, Pınar Keskinocak, Lauren N. Steimle, et al.
AJPM Focus (2022) Vol. 1, Iss. 1, pp. 100006-100006
Open Access | Times Cited: 3
Data-driven Targeting of COVID-19 Vaccination Programs: An Analysis of the Evidence on Impact, Implementation, Ethics and Equity
Zoë M McLaren
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Simultaneous Quantitative SARS-CoV-2 Antigen and Host Antibody Detection and Pre-Screening Strategy at the Point of Care
Kritika Srinivasan Rajsri, Michael P. McRae, Nicolaos Christodoulides, et al.
Bioengineering (2023) Vol. 10, Iss. 6, pp. 670-670
Open Access | Times Cited: 1
SARS-CoV-2 seroprevalence and infection rate in Manila, Philippines prior to national vaccination program implementation: a repeated cross-sectional analysis
Greco Mark Malijan, Tansy Edwards, Kristal An Agrupis, et al.
Tropical Medicine and Health (2022) Vol. 50, Iss. 1
Open Access | Times Cited: 2
A Prototype for Covid Risk Assessment: Designing a Chatbot for Users to Determine Personalized Risk of Severe Outcome
Joseph Tan
Journal of Quality in Health Care & Economics (2022) Vol. 5, Iss. 6, pp. 1-11
Open Access | Times Cited: 2
Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review
Nuru Saadi, Y-Ling Chi, Srobana Ghosh, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 1
Optimization Modeling for Pandemic Vaccine Supply Chain Management: A Review and Future Research Opportunities
S S Dey, Ali Kaan Kurbanzade, Esma S. Gel, et al.
arXiv (Cornell University) (2023)
Open Access
SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
Marco Bongiovanni, Elena Spada, Cristina de Angelis, et al.
Journal of Infection (2022) Vol. 84, Iss. 6, pp. e120-e121
Open Access
Can Vaccine Prioritization Reduce Disparities in Covid-19 Burden for Historically Marginalized Populations?
Erik Rosenstrom, Jessica Mele, Julie S. Ivy, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Page 1 - Next Page

Scroll to top